Incyte

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas.

CEO

William J. Meury

CEOWilliam J. Meury

Employees

2,617

Employees2,617

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,617

Employees2,617

INCY Key Statistics

Market cap

16.58B

Market cap16.58B

Price-Earnings ratio

19.07

Price-Earnings ratio19.07

Dividend yield

—

Dividend yield—

Average volume

1.75M

Average volume1.75M

High today

$85.98

High today$85.98

Low today

$83.51

Low today$83.51

Open price

$83.92

Open price$83.92

Volume

879.70K

Volume879.70K

52 Week high

$87.99

52 Week high$87.99

52 Week low

$53.56

52 Week low$53.56

INCY News

Simply Wall St 40m

Incyte: Valuation Update Following Pivotal Phase 3 Data for Povorcitinib

Here’s the latest on Incyte (INCY), and it’s news that could be shaping your view on what to do with the stock next. The company just released new 24-week inter...

Simply Wall St 4d

Could Patient-Focused Campaigns Like HS TRUTHS Shape Incyte’s Role in Immunodermatology?

On September 3, 2025, Incyte announced the launch of HS TRUTHS, an educational campaign designed to raise awareness about the realities of living with hidradeni...

Analyst ratings

52%

of 27 ratings

Buy

37%

Hold

51.9%

Sell

11.1%

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.